BRIANA SUAREZ: Open Payments
NPI 1699359042 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,531 in 107 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $509 · 2025 $1,531
Food & beverage: $1,274Education: $257
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $364 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $235 |
| Janssen Biotech, Inc. | 17 | $218 |
| Incyte Corporation | 26 | $206 |
| Novartis Pharmaceuticals Corporation | 16 | $173 |
| UCB, Inc. | 3 | $71 |
| Lilly USA, LLC | 2 | $47 |
| Organon LLC | 4 | $44 |
| Arcutis Biotherapeutics, Inc. | 2 | $43 |
| Biofrontera Inc. | 2 | $36 |
Products named: SKYRIZI, TREMFYA, OPZELURA, COSENTYX, Bimzelx, ILUMYA, VTAMA, Zoryve.
Industry payments across CA — which companies pay providers there.
